BioSpace News Archive

Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that it has submitted to the U.S. Food and Drug Administration a 505(b)(2) New Drug Application for its novel injectable formulation of cosyntropin (synthetic adrenocorticotropic hormone, or ACTH) depot with its partner, West Therapeutic Development, LLC. The application seeks approval for the use of this product as a diagnostic drug in the screening of patients presumed to have adrenocortical insufficiency.

Nektar Therapeutics announced early results from the ongoing dose-escalation stage of the first-in-human REVEAL Phase 1/2 clinical study evaluating the safety and efficacy of NKTR-262, a novel toll-like receptor 7/8 agonist, in combination with bempegaldesleukin*, a CD122-preferential IL-2 pathway agonist.

This notice has been updated to reflect a new active outbreak investigation of Salmonella illnesses linked to a frozen breaded chicken product that has been removed from the marketplace by the retailer.

Spectrum Pharmaceuticals, Inc. completed the sale of its portfolio of seven FDA-approved hematology/oncology products to Acrotech Biopharma L.L.C., a step-down subsidiary of Aurobindo Pharma Limited, India.

AAC Holdings, Inc. announced details for the release of its results for the fourth quarter and full year of 2018.

Liht Cannabis Corp. announces Corey Klassen has stepped-down from the Board of Directors to allow for and maintain an appropriate balance of experience and perspectives, with the implementation of changes in the near term.

New clinical data and case studies highlight the use of DiaResQ in a range of real world settings, from hospitals to disaster relief, in its first annual scientific meeting

Seventure Partners (Seventure), one of Europe’s leaders in financing innovation and a world-leader in the venture investment in the microbiome sector, is pleased to provide an update on its life science investments for the period September 2018 to February 2019.

Neurimmune today announced the appointment of John Dellapa as General Counsel. John joins Neurimmune from the Boston office of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, an AmLaw 100 law firm widely recognized for its outstanding life sciences practice.

In addition to demonstrating speed, agility and strength at the 2019 National Football League Scouting Combine, top college football players also undergo comprehensive physical evaluations that include X-ray exams.